However, our data does not exclude the possibilities of the involvement of others in the dysregulation of BARX1 in NSCLC tissues, such as aberrant chromatin remodeling and transcriptional activation, and somatic gene mutation. Here, BARX1 is linked to non-small cell lung carcinoma.